Report overview
Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy Testing Services. This report contains market size and forecasts of Hemoglobinopathy Testing Services in global, including the following market information:
Global Hemoglobinopathy Testing Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemoglobinopathy Testing Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hydroxyurea Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemoglobinopathy Testing Services include Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company and Celgene Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hemoglobinopathy Testing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoglobinopathy Testing Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, by Type, 2022 (%)
Hydroxyurea
Glutamine
Zynteglo
Luspatercept
Others
Global Hemoglobinopathy Testing Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, by Application, 2022 (%)
Sickle Cell Diseases
Thalassemia
Other
Global Hemoglobinopathy Testing Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoglobinopathy Testing Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemoglobinopathy Testing Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemoglobinopathy Testing Services, market overview.
Chapter 2: Global Hemoglobinopathy Testing Services market size in revenue.
Chapter 3: Detailed analysis of Hemoglobinopathy Testing Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoglobinopathy Testing Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
